Trailing-twelve-month (TTM) revenue is $22.98 Billion with a year-over-year growth of +2.17%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $5,748,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $5,593,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-19 |
| Q1 FY2026Period ended 2026-03-31 | $5,612,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q2 FY2026Period ended 2026-06-30 | $6,031,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $22,984,000,000 |
Current P/S: $53,108,819,630 market capitalization ÷ $22,984,000,000 TTM revenue = 2.31x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $6.03B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Investment Management | $2.0B | $2.1B | $2.0B | $2.1B | $2.3B | $2.6B |
| Investment Servicing | $9.7B | $9.8B | $10.1B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $5.3B | $5.4B | $5.2B | $5.1B | $5.5B | $5.9B |
| UNITED STATES | $6.5B | $6.7B | $7.0B | $6.8B |
$22.98B
$22.98 Billion
+2.17%
vs. $22.50B a year ago (TTM)
+14.50%
5 Year compound annual growth rate
1 Year
+2.17%
3 Year
+11.64%
5 Year
+14.50%
10 Year
+8.03%
15 Year
+5.64%
20 Year
+5.04%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $22.63B | +$655.00M | +2.98% |
| 2024 | $21.97B | +$3.61B | +19.64% |
| 2023 | $18.37B | +$4.70B | +34.36% |
| 2022 | $13.67B | +$1.64B | +13.62% |
| 2021 | $12.03B | ($39.00M) | (0.32%) |
| 2020 |
TTM Growth
+2.17%
3-Year CAGR
+11.64%
5-Year CAGR
+14.50%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $10.7B |
| $11.3B |
| Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment | N/A | N/A | N/A | N/A | N/A | $42M |
|---|
| $8.0B |
| $12.07B |
| ($1.06B) |
| (8.09%) |
| 2019 | $13.13B | +$9.00M | +0.07% |
| 2018 | $13.12B | +$1.25B | +10.55% |
| 2017 | $11.87B | +$1.24B | +11.61% |
| 2016 | $10.63B | ($125.00M) | (1.16%) |
